Literature DB >> 9756906

Activation of the prolactin gene by peroxisome proliferator-activated receptor-alpha appears to be DNA binding-independent.

R M Tolón1, A I Castillo, A Aranda.   

Abstract

Although the effects of the peroxisome proliferator-activated receptors (PPARs) have been studied primarily in adipocytes and liver, the wide distribution of these receptors suggests that they might also play a role in other cell types. We present evidence that PPAR activators stimulate the expression of the prolactin gene in pituitary GH4C1 cells. Transfection assays in non-pituitary HeLa cells showed that stimulation of the prolactin promoter by PPARalpha requires the presence of the transcription factor GHF-1 (or Pit-1). Proximal promoter sequences confer responsiveness to PPARalpha, and activation by this receptor is lost concomitantly with the response to GHF-1. Surprisingly, expression of the retinoid X receptor (RXR) abolishes stimulation by PPARalpha. Furthermore, the promoter region that confers PPARalpha responsiveness does not contain a PPAR response element. This suggests that the transcriptional effect of PPARalpha might be mediated by protein-protein interactions rather than by binding of PPAR/RXR to the promoter. A direct interaction between PPARalpha and GHF-1 was confirmed by in vitro binding studies. Expression of the coactivators SRC-1 and CREB-binding protein, which bind to PPAR, also enhanced the responsiveness of the prolactin promoter to PPARalpha. Furthermore, CREB-binding protein also significantly increased activation by GHF-1, and both proteins associated in vitro. Thus, PPARalpha, a receptor that normally acts as a ligand-dependent transcription factor by binding to specific DNA sequences in one context, can also stimulate the prolactin promoter by association with GHF-1 and coactivator proteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9756906     DOI: 10.1074/jbc.273.41.26652

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.

Authors:  Toru Akune; Shinsuke Ohba; Satoru Kamekura; Masayuki Yamaguchi; Ung-Il Chung; Naoto Kubota; Yasuo Terauchi; Yoshifumi Harada; Yoshiaki Azuma; Kozo Nakamura; Takashi Kadowaki; Hiroshi Kawaguchi
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

Review 2.  Distinct effects of PPARgamma insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells.

Authors:  Hiroshi Kawaguchi; Toru Akune; Masayuki Yamaguchi; Shinsuke Ohba; Naoshi Ogata; Ung-il Chung; Naoto Kubota; Yasuo Terauchi; Takashi Kadowaki; Kozo Nakamura
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

3.  Association with Ets-1 causes ligand- and AF2-independent activation of nuclear receptors.

Authors:  R M Tolón; A I Castillo; A M Jiménez-Lara; A Aranda
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

4.  Regulatory mechanisms controlling human hepatocyte nuclear factor 4alpha gene expression.

Authors:  P Hatzis; I Talianidis
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

5.  Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patients' survival.

Authors:  Stamatios Theocharis; Costas Giaginis; Aikaterini Parasi; Alexandra Margeli; John Kakisis; Emmanuel Agapitos; Gregorios Kouraklis
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

6.  A permissive retinoid X receptor/thyroid hormone receptor heterodimer allows stimulation of prolactin gene transcription by thyroid hormone and 9-cis-retinoic acid.

Authors:  Ana I Castillo; Ruth Sánchez-Martínez; Jose L Moreno; Olaia A Martínez-Iglesias; Daniela Palacios; Ana Aranda
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

Review 7.  Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications.

Authors:  Takeshi Matsumura; Kayo Taketa; Seiya Shimoda; Eiichi Araki
Journal:  J Diabetes Investig       Date:  2012-02-20       Impact factor: 4.232

8.  Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer.

Authors:  Hany N Azzam; Marwa O El-Derany; Sara A Wahdan; Reham M Faheim; Gouda K Helal; Ebtehal El-Demerdash
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

9.  Fasting Upregulates PPARalpha Target Genes in Brain and Influences Pituitary Hormone Expression in a PPARalpha Dependent Manner.

Authors:  Bettina König; Christine Rauer; Susann Rosenbaum; Corinna Brandsch; Klaus Eder; Gabriele I Stangl
Journal:  PPAR Res       Date:  2009       Impact factor: 4.964

10.  Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer.

Authors:  Costas Giaginis; Anna Tsantili-Kakoulidou; Stamatios Theocharis
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.